About: Persistence with osteoporosis medication among newly-treated osteoporotic patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Persistence with osteoporosis medication among newly-treated osteoporotic patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 April 2013

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2013 (uk) im April 2013 veröffentlichter wissenschaftlicher Artikel (de) 2013 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված (hy) scientific article published on 11 April 2013 (en) artículu científicu espublizáu n'abril de 2013 (ast)
publication date	wds:Q64135100-B0EB97CF-5CD5-4E15-A3F5-96D3B0630FF6
publication date	2013-04-11 00:00:00Z (xsd:dateTime)
exact match	wds:Q64135100-7CA87147-6944-424C-BFB9-4A2950F4D30F
exact match	https://scigraph.springernature.com/pub.10.1007/s00774-013-0440-2
cites work	wds:Q64135100-0D677619-D273-419E-AAA2-D054E6ADC169 wds:Q64135100-0FA0317A-3440-4890-828B-B8D16180AF55 wds:Q64135100-1565BAD9-7ED5-458F-ACE2-BC0432563F85 wds:Q64135100-2B88C997-D0AB-4E62-B51A-C96AB22D15D8 wds:Q64135100-303DD68B-68F6-44FC-9400-34F2BCBF88B7 wds:Q64135100-3687190E-337B-4890-9A6D-92EC9215760E wds:Q64135100-3EBD5B47-B455-454A-BEE3-A77DADFB65BB wds:Q64135100-3EEA651A-522C-4AD4-963B-682E4F6E8C28 wds:Q64135100-4F71D4CA-B7CC-486D-9605-209133AA8678 wds:Q64135100-5739ECD8-4EB1-4A7C-A256-9427C1DB2239 wds:Q64135100-67FDA4C2-F441-4952-A1F5-B83256BB7A97 wds:Q64135100-682EDE51-6B29-4D4F-9DF3-8C8529862F40 wds:Q64135100-6A5A9566-5D53-4C7A-B44B-DB98694B66FA wds:Q64135100-964A102A-1BA6-446A-B043-FC4AFD90981D wds:Q64135100-96A5C6A6-CA68-4AC8-ACA3-47F298F5733E wds:Q64135100-974B46A8-F14A-4E54-9A32-D6E0EF814705 wds:Q64135100-A9B24CE2-8EAB-44D3-8256-B079A9157121 wds:Q64135100-B20E609C-F1D7-4C06-B14A-04867B0A759B wds:Q64135100-B71077EC-A8E8-4AD2-924B-48F214ABA560 wds:Q64135100-BAD5EB6F-CC5E-4E57-955D-E1069EB92C95 wds:Q64135100-C70E8689-9CE5-4B4F-B8ED-2C366F157223 wds:Q64135100-D83AA0EC-661A-4626-9C81-9445E5C503D2 wds:Q64135100-DB04BC2E-91BA-4C47-B44F-319CB02CCAA6 wds:Q64135100-DF960C86-B1DD-44BD-BD34-7EFDF96CC75A wds:Q64135100-F269A08F-CB5C-4ED5-9DF0-3822E30C66D0
cites work	Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills A meta-analysis of osteoporotic fracture risk with medication nonadherence Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review Quality of life in patients with osteoporosis Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis Validity of a prescription claims database to estimate medication adherence in older persons Medication compliance and persistence: terminology and definitions Determinants of adherence to osteoporosis treatment in clinical practice. Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients The association between automatic generic substitution and treatment persistence with oral bisphosphonates Predictors of long-term persistence on statins in a subsidized clinical population Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. Measuring patient compliance in antihypertensive therapy--some methodological aspects. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information Differences in persistence among different weekly oral bisphosphonate medications Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).
author name string	wds:Q64135100-BCC5B1F2-373E-4A17-B479-E288CD465FC0
author name string	Pieter T de Boer
rdfs:label	Persistence with osteoporosis medication among newly-treated osteoporotic patients (en) Persistence with osteoporosis medication among newly-treated osteoporotic patients (nl)
skos:prefLabel	Persistence with osteoporosis medication among newly-treated osteoporotic patients (en) Persistence with osteoporosis medication among newly-treated osteoporotic patients (nl)
name	Persistence with osteoporosis medication among newly-treated osteoporotic patients (en) Persistence with osteoporosis medication among newly-treated osteoporotic patients (nl)
author	wds:Q64135100-7F2D7C58-F5AB-4B30-A907-1F9F8B2BE77C wds:Q64135100-8302977F-DAEC-4EFF-9D40-85CCA6F81BF6 wds:Q64135100-BBE8319E-3F51-48D2-A867-2E51A5D74033
author	Maarten J. Postma Job F.M. van Boven Stefan Vegter
title	wds:Q64135100-491B3A2D-FBB5-41CB-A540-F4D0AC26B1A2
title	Persistence with osteoporosis medication among newly-treated osteoporotic patients (en)
page(s)	wds:Q64135100-5FC1420A-6D15-4449-AB2B-FFB5EF2AECC5
page(s)	562-570
instance of	wds:Q64135100-1F760C09-74D7-4F67-A535-85183FDA07AC
instance of	scholarly article
PubMed ID	wds:Q64135100-A0ACE252-5364-4AB2-B1B2-93B592D6B7CA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23575910
PubMed ID	23575910
published in	wds:Q64135100-64AED853-3697-418D-92D0-74CD982FA0DB
published in	Journal of Bone and Mineral Metabolism
issue	wds:Q64135100-EB222A83-4C6B-4273-894A-CF9C3D132A07
volume	wds:Q64135100-DC5A3768-733D-4FDC-A440-327B9341DA1F
issue	5
volume	31
DOI	wds:Q64135100-4FC001CF-C4E6-4FB6-8FE4-75801170B89C
DOI	http://dx.doi.org/10.1007/S00774-013-0440-2
DOI	10.1007/S00774-013-0440-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64135100
is cites work of	Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis Long-term persistence with anti-osteoporosis drugs after fracture. Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. Improving adherence to and persistence with oral therapy of osteoporosis.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software